Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Should You Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up before the market opened on Friday . The stock had previously closed at $17.41, but opened at $19.13. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $19.26, with a volume of 7,366 shares.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on TLX shares. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group boosted their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The firm has a 50 day moving average price of $16.75.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.